Methylation of G3BP1 by PRMT5 Promotes TBK1 Recruitment for IRF3 Activation

Overview

This study identifies G3BP1 as a critical scaffold in innate immune signaling, facilitating TBK1 recruitment and IRF3 activation in response to extracellular RNA. G3BP1's arginine methylation by PRMT5 is essential for its interaction with TBK1 and subsequent interferon production.

Background

G3BP1 plays a significant role in the innate immune response by binding to key signaling molecules involved in the production of type I interferon. Understanding the mechanisms of G3BP1 in antiviral signaling is crucial, as dysregulation of this pathway can lead to inadequate immune responses during viral infections.

Data Highlights

No numerical data available in the source material.

Key Findings

• G3BP1 binds to TBK1 and IRF3, essential for IFN-β production.
• Knockdown of G3BP1 reduces TBK1-IRF3 complex formation and affects IRF3 phosphorylation.
• G3BP1 constitutively associates with IRF3 and recruits TBK1 upon stimulation.
• The C-terminal RGG region of G3BP1 is critical for binding IRF3 and TBK1.
• Arginine methylation of G3BP1 by PRMT5 is necessary for its interaction with TBK1.

Clinical Implications

The findings highlight the importance of G3BP1 in the antiviral immune response.

Conclusion

G3BP1 serves as a signaling hub that facilitates TBK1 recruitment and IRF3 activation through arginine methylation by PRMT5.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Blood Cancer Journal — B Cell Receptor Signaling Regulates APOBEC3 Expression Through Direct Enhancer Interaction in B Cells Affected by Chronic Lymphocytic Leukemia
3. Acta Neuropathologica — The RNA-binding protein IGF2BP1 influences the stability of mRNA derived from FOXM1 target genes in hypermitotic meningiomas.
4. Frontiers in Immunology — PRDM1-mediated epigenetic and transcriptional repression mechanisms: a key hub in immune differentiation, tumor progression, and inflammatory responses
5. Journal of Neuro-Oncology — Disruption of TRDMT1 Methyltransferase Influences the DNA Methylation Landscape in Glioblastoma Cells
6. IRF3 in viral infections: more than just triggering the interferon response - PubMed
7. Phase I dose-escalation and pharmacodynamic study of STING agonist E7766 in advanced solid tumors | Journal for ImmunoTherapy of Cancer
8. Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancers - ScienceDirect